Hans-Georg Lerchen is Chief Scientist in the Medical Chemistry department in the R&D organization of Bayer AG, Pharmaceuticals Division. With a 31 years background in MedChem he is author or co-author of 80 patents or patent applications and 21 publications. His current research focus is drug delivery modalities, prodrugs and in particular antibody drug conjugates.